Loading
institutionsInstitution
Melanoma Research Alliance
The melanoma research funder Debra and Leon Black started in 2007; it has put more than $200 million into research and every donated dollar goes to science because the founders cover the running costs.
Also called: MRA
Overview
The Melanoma Research Alliance was founded in 2007 by Debra and Leon Black after Debra's melanoma diagnosis. Its own overview states that it has directly invested over $200 million through more than 500 grant awards, that MRA-funded researchers have contributed to 20 new FDA-approved melanoma treatments since its founding, and that because the Blacks cover administrative and fundraising costs, 100% of every donation goes to melanoma research. It funds young investigators, team science and academic-industry partnerships, and convenes an annual scientific retreat. Headquartered in Washington, DC.
Location
Washington, DC, US
Type
consortium
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#421 · 12 points (0 Newsweek + 0 NCI + 12 from 6 linked objects) · ranking
- Young Investigator Awards
- Team Science Awards
- Academic-industry partnership awards
- Annual scientific retreat
Debra Black
Melanoma patient who co-founded the Melanoma Research Alliance
Melanoma research fundingPatient-founded foundations
Her 2007 melanoma diagnosis led her and her husband Leon to found the Melanoma Research Alliance, now the largest private funder of melanoma research.
Leon Black
Co-founder, with Debra Black, of the Melanoma Research Alliance
Melanoma research fundingPhilanthropy
After his wife Debra's melanoma diagnosis in 2007 the couple founded the Melanoma Research Alliance, which has put more than $200 million into research while they pay its running costs so every donated dollar goes to science.
Similar pages
- IdeaA public-benefit phase 1 factory that takes academic discoveries into first-in-human trials
Shares The valley of death between lab and product, Funding follows fashion, not burden.
- IdeaForty-eight-hour small grants for bold experiments in neglected cancers
Shares The valley of death between lab and product, Funding follows fashion, not burden.
- InstitutionEllison Institute of Technology
Shares The valley of death between lab and product, Funding follows fashion, not burden.
- PersonLarry Ellison
Shares The valley of death between lab and product, Funding follows fashion, not burden.
- InstitutionLudwig Cancer Research
Shares The valley of death between lab and product, Funding follows fashion, not burden, Immune checkpoint inhibitors.
- InstitutionWorldwide Cancer Research
Shares The valley of death between lab and product, Funding follows fashion, not burden.
- PersonJames P. Allison
Shares Leon Black, Melanoma, Immune checkpoint inhibitors.
- PersonAlfred P. Sloan Jr.
Shares The valley of death between lab and product, Funding follows fashion, not burden.